Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF
PHASE3
The purpose of this randomized, open-label, multicenter, active-controlled ...
Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV
PHASE2
The goal of this clinical study is to learn more about the safety and dosin...
Study in HIV1-Positive, Virosuppressed Patients Currently inTreatment With Ritonavir-Boosted Protease Inhibitors (PI/r) Starting Cobicistat-Boosted Darunavir (DRV/c - Rezolsta)
N/A
The purpose of this study is to describe the effectiveness of darunavir/cob...
Status
Completed
Location
Multiple Locations
Start Date
2016-07-22
Trial ID
NCT02926456
A Pilot,Raltegravir Versus NRTIs as a Backbone Switched From a Stable Boosted PI Regimen
NA
The purpose of this study is to determine whether raltegravir 400 mg b.i.d....
Status
Completed
Location
Hillsborough Health Department Specialty Care Center